Cel Sci Corporation New

CVM
1,42
-0,04 (-2,74%)
02 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
23/4/202415:00BWCEL-SCI Appoints Mario Gobbo to Its Board of Directors
19/3/202414:00BWCEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to..
07/3/202417:33EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/3/202417:33EDGAR2Form ARS - Annual Report to Security Holders
06/3/202414:45BWCEL-SCI Corporation Issues Letter to Shareholders
15/2/202414:00BWCEL-SCI Corporation Reports First Quarter Fiscal 2024..
14/2/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/2/202418:00BWCEL-SCI Announces Closing of $7.75 Million Public Offering..
09/2/202414:30BWCEL-SCI Announces Pricing of $7.75 Million Public Offering..
06/2/202415:00BWCEL-SCI Completes Commissioning of Its Multikine..
31/1/202415:00BWEuropean Medicines Agency Grants CEL-SCI a Waiver of Strict..
02/1/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202415:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202322:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/12/202314:00BWCEL-SCI Reports Fiscal 2023 Financial Results and Clinical &..
21/12/202322:15EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
04/12/202314:30BWUK’S National Institute for Health and Care Excellence..
20/11/202323:25EDGAR2Form 8-K - Current report
20/11/202322:15BWCEL-SCI Announces Closing of $5 Million Public Offering of..
16/11/202314:30BWCEL-SCI Announces Pricing of $5 Million Offering of Common..
30/10/202322:01EDGAR2Form 8-K - Current report
30/10/202314:20BWCEL-SCI Issues Letter to Shareholders
24/10/202316:18EDGAR2Form 8-K - Current report
24/10/202314:00BWCEL-SCI Releases Video Detailing Recent Phase 3 Findings &..
23/10/202315:15BW5-Year Head & Neck Cancer Survival Increased From 45% to 73%..
19/10/202314:00BWCEL-SCI Readies Its Multikine Manufacturing Facility for..
05/10/202314:45BWCEL-SCI Files Request With the UK’s MHRA Regarding Path to..
03/10/202316:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202316:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202316:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202315:00BWCEL-SCI Submits Scientific Advice Filing to European..
31/8/202323:16EDGAR2Form 8-K - Current report
11/8/202314:00BWCEL-SCI Corporation Reports Third Quarter Fiscal 2023..
10/8/202322:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
20/7/202322:10EDGAR2Form 8-K - Current report
20/7/202317:36BWCEL-SCI Announces Closing of Public Offering
18/7/202322:05EDGAR2Form 8-K - Current report
18/7/202303:23BWCEL-SCI Announces Pricing of Public Offering
17/7/202322:05BWCEL-SCI Announces Proposed Public Offering of Common Stock
14/7/202318:25EDGAR2Form 8-K - Current report
14/7/202315:15BWCEL-SCI Concludes Positive Meeting With U.S. FDA Concerning..
Apertura: 1,45 Min: 1,41 Max: 1,4866
Chiusura: 1,46

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network